However, the cut-off value of NT-proBNP needs to be systematically evaluated in the cancer population for prognosis, with or without HF, and its predictive value for the development of ventricular dysfunction, even asymptomatic, needs further investigation. The gene discussed is NPPB; the disease is cancer.